| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/02/2002 | EP1165084A1 Inhibitors of prenyl-protein transferases |
| 01/02/2002 | EP1165082A1 Inhibitors of prenyl-protein transferase |
| 01/02/2002 | EP1165068A1 C10 heterosubstituted acetate taxanes as antitumor agents |
| 01/02/2002 | EP1165013A2 Inhibitors of prenyl-protein transferase |
| 01/02/2002 | EP1164848A1 Compositions and methods for preventing and treating sexual dysfunctions |
| 01/02/2002 | EP0912553B1 BENZO[g]QUINOLINE DERIVATIVES |
| 01/02/2002 | EP0835256B1 Microbicidal benzotriazoles |
| 01/02/2002 | EP0731091B1 2-oxoindoline derivatives as cholecystokinin receptor antagonists |
| 01/02/2002 | CN1329609A Tetrahydrobenza epine derivatives useful as modulators of dopamine D3 receptors (antipsychotic agents) |
| 01/02/2002 | CN1329607A Substituted benzopyran analogs for treatment of inflammation |
| 01/02/2002 | CN1329600A Method for control of arthropods in animals |
| 01/02/2002 | CN1329596A Picolinamide derivatives and pest controllers containing same as active ingredient |
| 01/02/2002 | CN1329594A Ureidopiperidine derivatives as selective human NK3 receptor antagonists |
| 01/02/2002 | CN1329491A Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants |
| 01/02/2002 | CN1329003A Preparation method of optical purity lansoprazole |
| 01/02/2002 | CN1328824A Compound for curing female sexual disorder |
| 01/01/2002 | USRE37495 As pesticide, insecticide |
| 01/01/2002 | US6335463 Copper catalyzed arylation of 2,5-dichlorobenzoic acid with n-(4-fluorophenyl)glycine in which alkali metal salts are employed in aqueous alkaline environment |
| 01/01/2002 | US6335447 Bactericides |
| 01/01/2002 | US6335357 1-aryl-3-cyano-5-(het)arylalkylaminopyrazole derivatives; insecticides for agriculture and horticulture |
| 01/01/2002 | US6335351 Antiulcer agents and antisecretory agents of gastric juice; gastrointestinal disorder and psoriasis treatment; adenosine triphosphatase inhibitors |
| 01/01/2002 | US6335349 Agents that reduce levels of tumor necrosis factor; anticarcinogenic and antiinflammatory agents; treatment of autoimmune diseases |
| 01/01/2002 | US6335348 Administering pipecolic acid derivative as cognition activator and to treat eye and nervous system disorders |
| 01/01/2002 | US6335347 2-loratadine antiallergen |
| 01/01/2002 | US6335343 Inhibitors of prenyl-protein transferase |
| 01/01/2002 | US6335341 Anticholesterol agents; atherosclerosis |
| 01/01/2002 | US6335340 compounds of heteroaryl substituted imidazole, their pharmaceutical compositons and uses |
| 01/01/2002 | US6335336 Treating tumor necrosis factor and mitogen-activated protein kinase(map) mediated disorders; antiinflammatory and antiarthritic agents; inflammatory bowel disease |
| 01/01/2002 | US6335334 Hypertensive agents, anticoagulants; cardiovascular and sexual disorders, angina pectoris, and atherosclerosis |
| 01/01/2002 | US6335332 Barbituric acid derivatives with antimetastatic and antitumor activity |
| 01/01/2002 | US6335330 7-((4,4*-bipiperidin-1-yl)carbonyl)-2,3,4,5-tetrahydro-4--meth yl-3-oxo-1h-1,4-benzodiazepine-2-acetic acid hydrochloride; fibrinogen receptor antagonits, anticoagulants; prevention of strokes, restenosis |
| 01/01/2002 | US6335329 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 01/01/2002 | US6335327 1-benzazepine derivatives; agonists or antagonists of vasopressin and/or oxytocin |
| 01/01/2002 | CA2056799C 1,4-dihydropyridine derivatives and methods of producing the same |
| 01/01/2002 | CA2029105C Halogenated sulphonylaminocarbonyltriazolinones |
| 12/27/2001 | WO2001098295A1 Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them |
| 12/27/2001 | WO2001098294A2 Vitronectin receptor antagonist pharmaceuticals for use in combination therapy |
| 12/27/2001 | WO2001098293A1 Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals |
| 12/27/2001 | WO2001098284A1 Process for the preparation of pyrazolopyrimidinones |
| 12/27/2001 | WO2001098278A1 Methods and compositions utilizing quinazolinones |
| 12/27/2001 | WO2001098277A2 Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 12/27/2001 | WO2001098275A2 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
| 12/27/2001 | WO2001098273A1 Novel compounds |
| 12/27/2001 | WO2001098272A1 Novel compounds |
| 12/27/2001 | WO2001098270A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | WO2001098269A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | WO2001098268A2 Piperidine amides as modulators of chemokine receptor activity |
| 12/27/2001 | WO2001098267A1 3-azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity |
| 12/27/2001 | WO2001097861A2 Vitronectin receptor antagonist pharmaceuticals |
| 12/27/2001 | WO2001097848A2 Vitronectin receptor antagonist pharmaceuticals |
| 12/27/2001 | WO2001097811A1 Method for the treatment of overactive bladder |
| 12/27/2001 | WO2001097808A1 Combinations of depeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment of diabete mellitus |
| 12/27/2001 | WO2001097807A1 New use of angiotensin ii antagonists |
| 12/27/2001 | WO2001097787A2 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl) |
| 12/27/2001 | WO2001097753A2 Novel methods using pyridine derivatives |
| 12/27/2001 | WO2001085719A9 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 12/27/2001 | WO2001064645A3 Derivatives of quinoline as alpha-2 antagonists |
| 12/27/2001 | WO2001055116A3 Quinoline derivatives and their use as aurora 2 kinase inhibitors |
| 12/27/2001 | WO2001053268A3 Indazole compounds, pharmaceutical compositions, and their use for mediating or inhibiting cell proliferation |
| 12/27/2001 | US20010056191 Hydantoin-containing glucokinase activators |
| 12/27/2001 | US20010056184 Pipecolinic acid derivatives, method of manufacturing the same and therapeutic agents containing these compounds |
| 12/27/2001 | US20010056152 Chlorinated vinyl chloride resin composition |
| 12/27/2001 | US20010056123 Benzamidine derivatives |
| 12/27/2001 | US20010056113 Methods for the inhibition of angiogenesis with 6-amino EM-12 |
| 12/27/2001 | US20010056103 Non-immunosuppressive, piperidino or pyrrolidino amide derivative has an affinity for an FKBP-type immunophilin, useful for treating Alzheimer's Disease, Huntington's Disease, Parkinson's Disease, amyotrophic lateral sclerosis |
| 12/27/2001 | US20010056099 Method of reducing morbidity and the risk of mortality |
| 12/27/2001 | US20010056090 3-substituted piperidines comprising urea functionality, and methods of use thereof |
| 12/27/2001 | CA2413957A1 Vitronectin receptor antagonist pharmaceuticals for use in combination therapy |
| 12/27/2001 | CA2413421A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | CA2413418A1 Piperidine amides as modulators of chemokine receptor activity |
| 12/27/2001 | CA2413299A1 Combinations of dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment of diabetes mellitus |
| 12/27/2001 | CA2413277A1 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl) |
| 12/27/2001 | CA2413274A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | CA2412849A1 Vitronectin receptor antagonist pharmaceuticals for use in combination therapy |
| 12/27/2001 | CA2412188A1 3-azabicyclo¬3.1.0|hexane derivatives useful in therapy |
| 12/27/2001 | CA2411553A1 New use of angiotensin ii antagonists |
| 12/27/2001 | CA2411255A1 Novel compounds |
| 12/27/2001 | CA2410452A1 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
| 12/26/2001 | CN1328553A 3-Tetrahydropyridin-4-yl indoles for treatment of psychotic disorders |
| 12/26/2001 | CN1328552A Pyrimidone derivatives |
| 12/26/2001 | CN1328549A Substituted benzo [de] isoquinoline-1,3-diones |
| 12/26/2001 | CN1328547A 2,3-Disubstituted pyridine derivatives, process for preparation thereof, drug compositions containing the same and intermediates for preparation |
| 12/26/2001 | CN1328546A Pyrrolidines as inhibitors of neuraminidases |
| 12/26/2001 | CN1328471A Near infrared fluorescent contrast agent and fluorescence imaging |
| 12/26/2001 | CN1328451A Drugs for improving vesical excretory strength |
| 12/25/2001 | US6333341 Tumor necrosis factor, antiinflammatory agents and analgesics |
| 12/25/2001 | US6333340 Sulfonamides with oxo, ester or amide groups for vision defects and cognition activators |
| 12/25/2001 | US6333339 3-Benzylpiperidine |
| 12/25/2001 | US6333338 Anticoagulants, cardiovascular disorders |
| 12/25/2001 | US6333330 Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 12/25/2001 | US6333326 For therapy of neurodegenerative diseases selected from stroke, transient ischemic attack, peri-operative ischaemia, global ischaemia following cardiac arrest, and traumatic head injury to brain or spinal cord, epilepsy |
| 12/25/2001 | US6333325 Method of treating cytokine mediated diseases or conditions |
| 12/25/2001 | US6333296 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them |
| 12/25/2001 | CA2053640C Quinoline derivatives |
| 12/25/2001 | CA2052424C 2-(4-piperidinyl)-1h-pyrido¬4,3-b|indol-1-ones and related compounds, intermediates and a process for their preparation |
| 12/20/2001 | WO2001096331A1 Lactam inhibitors of factor xa and method |
| 12/20/2001 | WO2001096328A1 Indole derivatives useful for the treatment of cns disorders |
| 12/20/2001 | WO2001096327A1 BIOISOSTERIC BENZAMIDE DERIVATIVES AND THEIR USE AS APoB-100 SECRETION INHIBITORS |
| 12/20/2001 | WO2001096323A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096314A1 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines |